SHANGHAI, Feb. 6, 2026 /PRNewswire/ — Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration (NMPA). This follows the successful completion of Clinical Trial Notification (CTN) procedures and ethics committee approval in Australia in January 2026. Delonix plans to initiate Phase I clinical trials in the near term to evaluate the safety and immunogenicity of DX-104 in human subjects.
Invasive meningococcal disease (IMD) is a life-threatening bacterial infection that disproportionately impacts infants, adolescents, and young adults. Serogroup B has emerged as a predominant cause of IMD globally, accounting for approximately 50% of cases with a rising prevalence trend. While vaccines like GSK’s Bexsero® and Pfizer’s Trumenba® have established the commercial and clinical value of MenB prevention—with Bexsero recording approximately $1.58 billion in sales in 2025—significant global gaps in access and strain coverage remain.
DX-104 is an engineered MenB vaccine candidate developed using Delonix’s proprietary OMV Plus® platform. The platform leverages precisely engineered outer membrane vesicles (OMVs) with intrinsic adjuvant properties to optimize immunogenicity. In preclinical studies, DX-104 induced robust serum bactericidal antibody (SBA) responses without the need for external adjuvants. Furthermore, DX-104 has achieved commercial-scale production with high batch-to-batch consistency, ensuring a reliable global supply chain as the candidate advances toward potential commercialization.
“The dual regulatory clearances in China and Australia mark a transformative milestone for Delonix Bioworks as we transition into a clinical-stage company,” said Qiubin Lin, CEO and Founder of Delonix Bioworks. “This is a crucial step in our global strategy to deploy engineered bacterial vaccines that are designed to be highly immunogenic, well-tolerated, and scalable. We are committed to addressing the urgent unmet medical needs of patients worldwide.”
About Delonix Bioworks Delonix Bioworks is a clinical-stage biotechnology company at the forefront of developing next-generation genetically engineered bacterial vaccines. Leveraging its proprietary OMV Plus® platform, the company produces high-yield, cost-effective, and precisely engineered outer membrane vesicles (OMVs) designed for superior antigen presentation and immunogenicity. Delonix is dedicated to advancing a robust pipeline of first-in-class and best-in-class programs addressing critical unmet needs, including vaccines for Meningococcal B, pertussis, gonorrhoeae, and K. pneumoniae.
BEIJING, Feb. 6, 2026 /PRNewswire/ — LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a notice, dated February 4, 2026, from legal counsel to a group (the “Buyer Group”) consisting of Oceanpine Skyline Inc. (“Parent”), Oceanpine Merger Sub Inc. (“Merger Sub”), Oceanpine Capital Inc., Oceanpine Investment Fund II LP, Crystal Peak Investment Inc., Adjuvant Global Health Technology Fund, L.P., Adjuvant Global Health Technology Fund DE, L.P., Superstring Capital Master Fund LP, MSA GROWTH FUND II, L.P., and Epiphron Capital (Hong Kong) Limited, relating to the previously announced going-private transaction of the Company whereby the Buyer Group agreed to take the Company private at a price of $0.90 per share pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated November 4, 2025, by and among the Company, Parent and Merger Sub.
According to the notice, the Buyer Group asserted that the arbitral awards received by the Company from the Kaifeng Arbitration Commission on January 21 and January 22, 2026—previously disclosed in the Company’s current report on Form 6-K furnished with the Securities and Exchange Commission (the “SEC”) on January 29, 2026—and the resulting financial liability of approximately RMB576,500,000 constitute a “Company Material Adverse Effect” under the Merger Agreement.
The Buyer Group asserted that a condition precedent to Parent’s obligation to close the Merger (as defined in the Merger Agreement) is that no Company Material Adverse Effect (as defined in the Merger Agreement) shall have occurred, and the Buyer Group has determined that a Company Material Adverse Effect has occurred and that the Buyer Group has the right not to consummate the Merger. The Buyer Group indicated that it would not attend or cast votes at the upcoming extraordinary general meeting (the “EGM”), scheduled for February 12, 2026, to consider and vote on, among other matters, the proposal to authorize and approve the Merger Agreement, the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, and the transactions contemplated thereby, including the Merger.
The Buyer Group expressed its willingness to engage in good faith discussions with the Company to explore amendments to the transaction terms to facilitate a mutually acceptable resolution and the successful completion of the transaction.
In light of this development, the Company has decided to postpone the previously announced EGM. Any proxy cards that have been submitted to the Company in respect of the EGM will be disregarded. Shareholders of record as of 5 p.m.Cayman Islands time on January 16, 2026 will each receive a copy of the notice regarding the postponement of the EGM. The notice will also be available on the Company’s website at https://investors.lakeshorebio.com/index.html and on the SEC’s website at http://www.sec.gov.
The Company will carefully review and evaluate the Buyer Group’s claims and the Company’s options, and will provide further updates as required under applicable law.
About LakeShore Biopharma Co., Ltd
LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry.
This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements include, without limitation, the Company’s business plans and development, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “future,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. LakeShore Biopharma may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about LakeShore Biopharma’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the possibility that events may arise that result in the termination or amendment of the Merger Agreement; the possibility that competing offers will be made; the possibility that financing may not be available; the possibility that various closing conditions for the transaction may not be satisfied or waived; and other risks and uncertainties discussed in documents filed with the SEC by the Company, as well as the Schedule 13E-3 and the proxy statement filed by the Company; the Company’s goals and strategies; the Company’s future business development, financial condition and results of operations; its ability to provide efficient services and compete effectively; its ability to maintain and enhance the recognition and reputation of its brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
Combination to Create End-to-End Trading Suite for Global Futures and Options Markets
DENVER, Feb. 6, 2026 /PRNewswire/ — CQG, a leading provider of futures and options trading, execution management and market connectivity, today announced it has entered into an agreement with global Fintech leader Broadridge Financial Solutions, Inc. (NYSE:BR) for Broadridge to acquire CQG. CQG will add complementary execution management, algorithmic trading and analytics capabilities to Broadridge’s order management and client connectivity solutions, creating an end-to-end trading suite for global futures and options markets.
“Our combined capabilities will provide a global multi-asset class trading experience defined by speed, scale and intelligence,” said Ryan Moroney, CEO of CQG. “Broadridge’s deep global reach and front-to-back capabilities and our expertise in front-office execution management and connectivity will enable clients to trade smarter, access new markets and adapt faster in an increasingly connected futures and options marketplace. The CQG team is truly excited to join a company with the history and successful track record of Broadridge.”
“The acquisition of CQG will accelerate Broadridge’s mission to deliver advanced, highly connected trading solutions on a global scale,” said Frank Troise, President of Broadridge’s Trading and Connectivity Solutions business. “Integrating CQG’s advanced execution management, analytics and connectivity technologies with Broadridge’s leading order management and connectivity solutions will create a unified platform in futures and options that simplifies trading complexity, improves transparency and workflow efficiency, and enhances Broadridge’s digital asset trading capabilities.”
Moroney added: “Broadridge has been a terrific partner since we decided to integrate some of our technologies a few years ago, and the team has made it clear they value our talented employees, culture, loyal client base, rapid delivery of new functionality and innovation. In this fast-moving environment, we believe the shared values between our firms, along with our combined global reach, significant resources and complementary technology make this transaction so compelling for CQG and exactly the right step for our employees and customers.”
Terms of the transaction, which are not expected to have a material impact on Broadridge’s financial results, were not disclosed. The transaction is expected to close early in Broadridge’s fiscal fourth quarter that ends June 30, subject to customary closing conditions, including regulatory approvals.
The expanded offering is designed to better support the evolving end-to-end needs of clients across a broad spectrum of segments, including futures commission merchants (FCMs), institutional investors, retail brokers, proprietary trading firms, commodity trading advisors (CTAs) and hedge funds. Clients will benefit from flexible, scalable solutions designed to support their growth objectives, accelerate speed to market, and deliver a powerful, fully integrated trading experience for institutional and professional retail market participants alike.
About CQG
CQG provides the industry’s highest performing solutions for traders, brokers, commercial hedgers and exchanges for their market-related activities globally, including trading, market data, advanced technical analysis, risk management, and account administration. The firm partners with the vast majority of futures brokerage and clearing firms and provides Direct Market Access (DMA) to more than 45 exchanges through its global network of co-located Hosted Exchange Gateways. CQG technology serves as the front end for a variety of exchanges and is increasingly employed as the over-the-counter matching engine for important new markets. CQG’s server-side order management tools for spreading, market aggregation, and smart orders are unsurpassed for speed and ease of use. Its market data feed consolidates 85 sources, including exchanges worldwide for futures, options, fixed income, foreign exchange, and equities, as well as data on debt securities, industry reports, and financial indices. One of the longest-serving technology solutions providers in the industry, CQG has won numerous awards for its trading software, technical analysis and multi-asset trading platform. CQG is headquartered in Denver, with sales and support offices and data centers in key markets globally, providing services in more than 60 countries. For more information, visit www.cqg.com.
About Broadridge
Broadridge Financial Solutions (NYSE: BR) is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate and grow. The firm powers investing, governance and communications for its clients – driving operational resiliency, elevating business performance and transforming investor experiences.
Broadridge’s technology and operations platforms process and generate over 7 billion communications annually and underpin the daily average trading of over $15 trillion in equities, fixed income and other securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing over 15,000 associates in 21 countries.
BASKING RIDGE, N.J., Feb. 6, 2026 /PRNewswire/ — Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL. PYQUVI, a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older, is bioequivalent to Emflaza® (deflazacort) oral suspension 22.75 mg/mL.
PYQUVI will be available exclusively through a specialty pharmacy, offering an option for patients with DMD who prefer to receive deflazacort via a specialty pharmacy channel.
“Patients living with Duchenne muscular dystrophy and their families often face complex treatment-access considerations, including navigating evolving standards of care and insurance coverage variability that can delay timely therapy. These challenges add to the daily burden of a progressive condition such as Duchenne muscular dystrophy and underscore the importance of clear pathways to appropriate treatment and support,” said Dr. Marie Tan, Associate Director of Medical Affairs, Clinical Operations, and Pharmacovigilance at Aucta Pharmaceuticals, Inc. “As part of the PYQUVI launch, Aucta plans to offer a patient support program focused on access and specialty pharmacy coordination for eligible patients.”
The launch of PYQUVI marks Aucta Pharmaceuticals’ first commercial branded-generic product in the United States. Building on this milestone, Aucta Pharmaceuticals will be introducing ZELVYSIATM (sapropterin dihydrochloride) Powder for Oral Solution. ZELVYSIA is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). ZELVYSIA is to be used in conjunction with a Phe-restricted diet.
ZELVYSIA is anticipated to launch in March 2026, shortly following the introduction of PYQUVI.
Together, these launches represent a significant step forward in Aucta Pharmaceuticals’ branded generic portfolio. It also underscores our commitment to providing treatment options for patients and families affected by rare conditions.
Emflaza® is a registered trademark of PTC Therapeutics, Inc.
INDICATION
PYQUVITM is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
IMPORTANT SAFETY INFORMATION
PYQUVI is contraindicated in patients with a hypersensitivity to deflazacort or any of the inactive ingredients.
WARNINGS AND PRECAUTIONS
Alterations in Endocrine Function: Corticosteroids can cause serious and life-threatening endocrine alterations, especially with chronic use. Monitor for Cushing’s syndrome, hyperglycemia, and adrenal insufficiency after withdrawal. Risk is higher in patients with hypopituitarism, primary adrenal insufficiency, congenital adrenal hyperplasia, altered thyroid function, or pheochromocytoma. Acute adrenal insufficiency or “withdrawal syndrome” may occur if discontinued abruptly and can be fatal; taper gradually. Dose may need to be increased during times of medical stress.
Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe or fatal. Signs of infection may be masked. Advise patients/caregivers to report recent infections or vaccinations. Patients without prior chickenpox or measles should avoid exposure and contact their healthcare provider immediately if exposed.
Alterations in Cardiovascular/Renal Function: Monitor blood pressure; dietary salt restriction and potassium supplementation may be needed.
Gastrointestinal (GI) Perforation: Risk is increased in patients with certain GI disorders (e.g., active or latent peptic ulcers, diverticulitis, recent intestinal anastomoses, inflammatory bowel disease). Signs may be masked.
Behavioral and Mood Disturbances: May include euphoria, insomnia, mood swings, personality changes, depression, and psychosis. Advise patients to seek medical attention if symptoms develop or worsen.
Effects on Bones: Prolonged use increases risk of osteoporosis, and vertebral and long bone fractures. Monitor bone density with chronic use.
Ophthalmic Effects: May cause cataracts, ocular infections, or glaucoma. If corticosteroids are used for >6 weeks, monitor intraocular pressure.
Vaccination: Do not administer live or live-attenuated vaccines during immunosuppressive corticosteroid therapy. Administer such vaccines at least 4 to 6 weeks before starting PYQUVI.
Serious Skin Rashes: Toxic epidermal necrolysis has been reported. Discontinue at the first sign of rash, unless the rash is clearly not drug related.
Effects on Growth and Development: Long-term use of corticosteroids may slow growth and development in children.
Thromboembolic Events: Observational studies have shown an increased risk. Use with caution in at-risk patients.
ADVERSE REACTIONS
The most common adverse reactions (≥10% and greater than placebo) are Cushingoid appearance, weight gain, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
DRUG INTERACTIONS
Moderate or strong CYP3A4 inhibitors: Use one third of the recommended PYQUVI dose.
Moderate or strong CYP3A4 inducers: Avoid concomitant use as efficacy may be reduced.
To report SUSPECTED ADVERSE REACTIONS, contact Aucta Pharmaceuticals, Inc. at 1-800-655-9902, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
ZELVYSIATM (sapropterin dihydrochloride) is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients 1 month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). ZELVYSIA is to be used in conjunction with a Phe-restricted diet.
IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
Hypersensitivity Reactions, Including Anaphylaxis: Avoid use in patients with a history of anaphylaxis to sapropterin. Discontinue treatment if anaphylaxis occurs and initiate appropriate medical care. Continue dietary Phe restrictions.
Upper Gastrointestinal (GI) Mucosal Inflammation: Serious GI adverse reactions (eg, esophagitis, gastritis, ulcer, bleeding) have been reported. Monitor for signs and symptoms.
Hypophenylalaninemia: May occur; increased risk in children <7 years of age treated with doses of 20 mg/kg per day. Monitor closely.
Blood Phe Monitoring: Frequent blood Phe monitoring is required to ensure levels remain in the desirable range. Prolonged high Phe can cause severe neurologic damage (eg, intellectual disability, developmental delay, microcephaly, delayed speech, seizures, behavioral abnormalities). Prolonged low Phe can lead to catabolism and adverse developmental outcomes. Active management of dietary protein and Phe restriction is required.
Lack of Biochemical Response: Not all patients with PKU respond. Assess response through a therapeutic trial; response cannot be pre-determined by laboratory testing.
Interactions with Levodopa: May cause seizures, exacerbation of seizures, overstimulation, or irritability. Monitor for changes in neurologic status.
Hyperactivity: Monitor for signs of hyperactivity.
ADVERSE REACTIONS
The most common adverse reactions (incidence ≥4%) are headache, rhinorrhea, pharyngolaryngeal pain, diarrhea, vomiting, cough, and nasal congestion.
DRUG INTERACTIONS
Folate Synthesis Inhibitors (e.g., methotrexate, valproic acid, phenobarbital, trimethoprim): May decrease BH4 and increase Phe. Monitor Phe more frequently; adjust dosage as needed.
PDE-5 Inhibitors (e.g., sildenafil, vardenafil, tadalafil): Both ZELVYSIA and PDE-5 inhibitors may induce vasorelaxation and hypotension. Monitor blood pressure.
To report SUSPECTED ADVERSE REACTIONS, contact Aucta Pharmaceuticals, Inc. at 1-800-655-9902, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information, including Patient Information, and Instructions for Use.
About Aucta Pharmaceuticals, Inc.
Aucta Pharmaceuticals, Inc. is a research and technology-based pharmaceutical company focusing on the development and commercialization of niche generic and branded specialty products. The company’s corporate strategy is to focus on proven molecules and, through innovation, create new therapeutics with lower scientific risk that fulfill unmet medical needs. Its specialty division has a therapeutic focus in neurology/epilepsy, nasal delivery, and other specialty fields. For more information, visit www.auctapharma.com.
JAKARTA, INDONESIA – Media OutReach Newswire – 6 February 2026 – 2026 marks the 35th anniversary of the establishment of dialogue relations between China and ASEAN and the 5th anniversary of the establishment of the China-ASEAN Comprehensive Strategic Partnership. It also coincides with the Year of the Horse in Chinese Spring Festival. On February 5, the “Steeds Herald Spring, Blessings Fill ASEAN”—Spring Festival @ ASEAN Headquarters 2026 was successfully held at the ASEAN Headquarters in Jakarta, Indonesia.
The Chinese Ambassador to ASEAN and representatives of the Guangxi government pose for a handshake group photo with the permanent representatives of the 11 ASEAN member states (Photo by Huang Jundong)
The event, supported by the Mission of the People’s Republic of China to ASEAN, the Permanent Mission of Malaysia to ASEAN, and the ASEAN Secretariat, was hosted by the Information Office of the People’s Government of Guangxi Zhuang Autonomous Region, China, and the Department of Culture and Tourism of Guangxi Zhuang Autonomous Region, China, and jointly organized by Guangxi Daily (Guangxi International Communication Center), Guangxi Radio and Television, Guangxi Tourism Development Group, and Guangxi Cultural Industry Group. More than 250 guests attended the event, including envoys from the 11 ASEAN countries and external partners such as Russia, the United Kingdom, Australia, South Korea, and Brazil, senior officials from the ASEAN Secretariat, representatives from mainstream ASEAN media, local university faculty and students, and representatives from Chinese-funded enterprises.
I. A Gathering of Distinguished Guests, Sharing a Common Vision
This marks the first time that Chinese Spring Festival cultural activities have been held at the ASEAN Headquarters. With the deepening of globalization, the traditional festival of Spring Festival is not only a time for family reunions for the Chinese people, but also a new bond for dialogue between different civilizations. The Chinese Spring Festival embodies the philosophy of “harmony and coexistence”, which aligns perfectly with the ASEAN countries’ pursuit of “unity and cooperation”. Furthermore, the sustainable development concept of “rejuvenating the old and welcoming the new” resonates strongly with the ASEAN region’s vision of “common prosperity”.
Kao Kim Hourn, Secretary-General of ASEAN, stated in his video address that over time, the Spring Festival has evolved into a global celebration. Its inscription on the UNESCO’s Representative List of the Intangible Cultural Heritage of Humanity in 2024 underscores the rich significance of this precious human heritage. Within ASEAN, many member states celebrate the Spring Festival, reminding people of the deep emotional bonds that transcend national borders. ASEAN will continue its commitment to fostering a community proud of its identity, actively undertaking the responsibility of protecting, preserving, and creating culture, arts, and traditions, and promoting the development of the cultural and creative industries. As we welcome the Year of the Horse, we hope everyone will embrace the elegance, vitality, and forward momentum that the horse represents, and embark on the new year together with hope, resilience, and unity.
Wang Qing, Chinese Ambassador to ASEAN, stated in his address that the Spring Festival symbolizes reunion, joy, and harmony. Celebrating the holiday together exemplifies the close bonds between the people of China and ASEAN, the integration of our civilizations, and our harmonious coexistence. The China-ASEAN community with a shared future is growing ever closer, demonstrating powerful vitality and setting an exemplary model for building a community with a shared future for mankind. He specifically noted that Guangxi serves as a vital “connection point” and “intersection point” for China-ASEAN friendship, exchanges, and cooperation, functioning as both a “gateway and engine” within the China-ASEAN Comprehensive Strategic Partnership. In the new year, he extended heartfelt wishes for China-ASEAN friendship and cooperation to surge forward like galloping horses, unstoppable in its momentum.
Ambassador Sarah, Permanent Representative of Malaysia to ASEAN, noted in the address that as the Country Coordinator for China-ASEAN Relations, Malaysia has been privileged to witness and foster the flourishing development of the China-ASEAN Comprehensive Strategic Partnership. Cultural celebrations like today’s Spring Festival event vividly demonstrate that our partnership extends far beyond trade agreements and diplomatic protocols. ASEAN and China share a deep, mature, and resilient relationship that will continue to grow and strengthen on the solid foundation of mutual respect, shared interests, and a common vision for peace, stability and prosperity in the region.
Li Pan, Director of the Information Office of the People’s Government of Guangxi Zhuang Autonomous Region, stated in his address that Guangxi is honored to host this event at the ASEAN Headquarters. As the permanent host city of the China-ASEAN Expo, Guangxi serves as an important platform for China-ASEAN economic and trade cooperation and cultural exchanges. Guangxi is working with ASEAN countries to build an artificial intelligence development path of “R&D in Beijing, Shanghai, and Guangzhou + Integration in Guangxi + Application in ASEAN”, and actively creating a new trade chain of “Production in ASEAN + Distribution in Guangxi + Sales in China”. In 2026, Guangxi will work hand in hand with all sectors of ASEAN to forge ahead and strengthen the neighborly bond between China and ASEAN over time. II. Celebrating the Spring Festival and Savoring the Festive Flavors
The event invited guests from around the world to gather together, celebrating the Spring Festival for the Year of the Horse, savoring the flavors of the Chinese Spring Festival, and appreciating the beauty of the arts. The opening performance, “The Beauty of China: Guangxi’s Zhuang Ethnic Charm”, featured a symbolic dance and connected it with a classic excerpt from the Caidiao Opera “Liu Sanjie”, including the “Antiphonal Song”, creating an artistic masterpiece that blends Eastern poetry with innovative ingenuity. The Chinese instrumental performance, “Chinese Chic Performance for Celebrating the Spring Festival of the Year of the Horse”, featured erhu and suona as the main instruments, playing classic melodies such as the theme song from “Journey to the West” and “Black Myth: Wukong”, converging into a “National Trend IP Music Festival”. When Guangxi ethnic instruments, the maguhu (horse-bone fiddle) and the bolie, met Indonesian gamelan, Chinese and Indonesian musicians jointly performed classics like “Jasmine Flower” and “Folk Songs Like Spring River Water”making the phrase “high mountains and flowing water meet a kindred spirit” more concrete and creating a lasting artistic resonance.
During the event, Guangxi Daily (Guangxi International Communication Center), Guangxi Radio and Television, together with ASEAN media such as TVRI, El John TV, and Harian Inhua, jointly launched the China-ASEAN Spring Festival Short Video Exhibition Week. Using short videos as a link, the event showcased the joyous scenes of China and ASEAN countries celebrating the Spring Festival together from multiple dimensions, inviting netizens around the world to jointly celebrate the Chinese Spring Festival as a global festival through the Internet.
III. Savoring the Cultural Gathering, Welcoming the Prosperous Spring Festival
On the same day, the “Spring Blessings for Success at the Year of the Horse” Chinese Spring Festival Cultural Exhibition and the “Instant Joy Market” Spring Festival Cultural Market were held simultaneously at the ASEAN Headquarters. Guests from various countries experienced the hospitality of “Tea Harmonies the World” through immersive experiences that included playing, appreciating, and tasting, creating “Ancient Charm and Blessings” calligraphy and painting rubbings, admiring the exquisite paper-cutting art, and enjoying a feast of Spring Festival delicacies from all directions.
The most surprising experience for the guests was exploring the smart future using Guangxi’s cutting-edge AI technology. Guests from various countries experienced intelligent translation devices and wore AR glasses, immersing themselves in barrier-free communication and exploring the thousand-year-old legend of the Zuojiang Huashan Rock Art Cultural Landscape. Hardy Chung, a reporter from Harian Inhua, remarked that China’s AI technology not only accurately depicted the beautiful scenery of the Spring Festival but also vividly expressed the touching story of ASEAN and China being connected by mountains and seas and sharing good neighborly friendship, presenting a beautiful picture of cooperation towards the future.
On February 4th, two “Instant Blessings” Pop-Up Events were held at the Halim Station of the Jakarta-Bandung High-Speed Railway and the Mall Central Park in Jakarta, Indonesia, creating a festive atmosphere for the Chinese Spring Festival. Performers from Guangxi presented a variety of acts including song, dance, opera, and puppetry, attracting many locals to participate in interactive activities, join in the “Guangxi Kemusan Dance”, and share the joy of the Spring Festival. Yi Yan, a social media blogger traveling and living in Indonesia, exclaimed, “This year’s Spring Festival atmosphere in Jakarta is different!”
This event attracted more than 20 media outlets, including People’s Daily, Xinhua News Agency, China Media Group, China News Service, TVRI, METRO TV, bolong.id, and Vietnam News Agency to report on the event and widely spread the concepts of peace, amity, and harmony in the Spring Festival to people at home and abroad.
The issuer is solely responsible for the content of this announcement.
SHANGHAI, Feb. 6, 2026 /PRNewswire/ — Lanvin Group (NYSE: LANV) today announced that it has completed the sale of Caruso, a luxury Italian menswear manufacturer and brand, to MondeVita Italy S.r.l., a subsidiary of Mondevo Group.
The transaction reflects Lanvin Group’s commitment to focus on the sustainable development of heartland brands. For Mondevo Group, the acquisition marks a defining moment in the build-up of MondeVita, its dedicated lifestyle and luxury division, focused on consolidating and elevating exceptional heritage brands across premium beverages, luxury goods, hospitality, and wellness.
About Lanvin Group
Lanvin Group is a leading global luxury fashion group headquartered in Shanghai, China and Milan, Italy, managing iconic brands worldwide including Lanvin, Wolford, Sergio Rossi and St. John Knits. Harnessing the power of its unique strategic alliance of industry-leading partners in the luxury fashion sector, Lanvin Group strives to expand the global footprint of its portfolio brands and achieve sustainable growth through strategic investment and extensive operational know-how, combined with an intimate understanding and unparalleled access to the fastest-growing luxury fashion markets in the world. The shares of Lanvin Group are listed on the New York Stock Exchange under the ticker symbol “LANV”. For more information about Lanvin Group, please visit www.lanvin-group.com, and to view Lanvin Group’s investor presentation, please visit https://ir.lanvin-group.com.
About MondeVita
MondeVita is the lifestyle and luxury division of Mondevo Group, created in response to a clear desire among family offices to invest in sectors they are genuinely passionate about – from premium beverages and luxury goods to hospitality and wellness. These sectors are rich with opportunity but remain highly fragmented, with niche players operating in limited geographies and often constrained by insufficient capital or lack of strategic expertise. MondeVita aims to consolidate and elevate this landscape by building a portfolio of best-in-class companies that can thrive through shared capabilities, cross-portfolio synergies, and economies of scale.
About Mondevo Group
Mondevo Group is a multi-divisional holding company headquartered in Abu Dhabi, operating at the intersection of technology, investment, and lifestyle. The group’s divisions span wealth management, venture capital, luxury and lifestyle, and foundational technology platforms. Mondevo’s mission is to harness AI-native capabilities and a global network of ultra-high-net-worth families to build enduring businesses across sectors with high barriers to entry and strong long-term growth potential.
About Raffaele Caruso S.p.A.
Raffaele Caruso S.p.A. is an Italian company active in high-end sartorial manufacturing, headquartered in Soragna (Parma). Founded in 1964, the company operates as a trusted industrial partner to some of the world’s most prestigious global fashion houses and develops, through the Caruso brand, menswear collections distributed through a selective network of high-end multi-brand retailers. The Caruso brand is recognised for its distinctive positioning of Playful Elegance, combining sartorial rigour, lightness and a contemporary interpretation of Italian style. With over 450 employees, Raffaele Caruso S.p.A. brings together manufacturing expertise, industrial scale and a strong brand identity.
CHENNAI, India, Feb. 6, 2026 /PRNewswire/ — India’s top-ranked higher education, the Indian Institute of Technology Madras (IIT Madras), has established a new entity, IIT Madras Global Research Foundation (IITM Global) with a charter to take IIT Madras’ research and innovation ecosystem into multiple geographies.
Indian External Affairs Minister Dr S Jaishankar (3rd L) releases a book on ‘India’s Innovation Ecosystem Going Global’ on 2 Jan at IITM, India
IITM Global is strengthening its engagement in Southeast Asia through strategic partnerships in Malaysia. IITM Global was newly-launched by Dr. S. Jaishankar, Hon’ble Minister of External Affairs, Government of India.
The initiative supports IIT Madras’s vision to become the world’s first multinational university by positioning it as a globally networked hub for education, research, innovation and entrepreneurship.
Addressing the IITM Global launch event at IIT Madras Campus on 2nd Jan 2026, Dr. S. Jaishankar said,“An IIT Madras Campus in Tanzania is a way by which Indian Foreign Policy has leveraged the capabilities of an Institution here to make a huge impact. In ten years from now, think how many Students of Africa would have passed through its portals. We are a human resource power and we should play to our strengths. We now have the capability to start doing so. When institutions of excellence in the country start going abroad, the business of foreign policy gains a huge addition to our arsenal. This is something very transformational.”
As part of its Malaysia-focused expansion, IIT Madras has entered into a collaboration with ASEM (Advanced Semiconductor Academy of Malaysia) to deepen academic cooperation and innovation-led engagement in the region. The partnership will focus on delivering joint certification programs, enabling student exchange and faculty mobility, and supporting education and skilling initiatives tailored to Malaysian and regional needs with a focus on Semiconductors & Semiconductor design.
In addition, the partnership envisions setting up an Overseas Research Centre in Malaysia to support high-potential deep-tech startups seeking to expand into the Southeast Asian market.
IITM Global has also formalised a collaboration framework with Aisling Group. The partnership is designed to build synergies aligned with IITM Global’s mission to internationalise Indian innovation, technology and startups.
Areas of collaboration include startup scaling support, Skilling and short term certification programs, collaborative research initiatives, and intellectual property and technology transfer, enabling closer integration between Indian and Malaysian innovation ecosystems.
IITM Global has been conceived as a strategic, scalable ‘plug-and-play’ platform that enables researchers, students, startups and industry partners to access global markets, capital and collaborative research opportunities.
Widely recognised as India’s top-ranked institution for higher education, IIT Madras is ranked #1 Overall and #1 Engineering Institute in India’s National Institutional Ranking Framework (NIRF), #180 in the QS World University Rankings and #56 in the QS Asian University Rankings. The institute brings a strong research ecosystem to its global partnerships, comprising 18 academic departments, 15 Centres of Excellence, 23 research centres and nearly 100 advanced laboratories, supported by more than 650 faculty members and over 10,000 students.
Marvel at the Whimsical Gallop of Horses Adorned in Embroidered Artistry, Alongside an AI Fai Chun Photo Booth and Joyful New Year Rewards
HONG KONG SAR – Media OutReach Newswire – 6 February 2026 – This Chinese New Year, Pacific Place and Starstreet Precinct invite you to take a joyful gallop into the Year of the Horse with ‘Whimsical Gallop’ — a celebration that blends artistry, imagination and auspicious cheer. From 5 February to 3 March 2026, the mall is transformed into a contemporary Chinese garden awash in soft, nature-inspired pink hues. Leading the way is a striking 3.5-metre-tall embroidered horse in Park Court, alongside three other beautifully adorned horses brought to life by Hong Kong embroidery atelier YLYstudio. Together, this quartet of horses brings luck and fortune to all.
Spring Bloom Gallop Pavilion
Beyond the installations, the festivities continue with thoughtful and playful experiences. Create your own personalised blessings at the ‘Splendid Blessings’ AI Fai Chun Photo Booth, and enjoy ‘Galloping Joy’ New Year Shopping Rewards with festive ‘Blooming Splendour’ Lai See packets and exclusive shopping treats. The celebration culminates with lively jazz tap dance performances and a lion dance parade, bringing heritage and modern festivity together for everyone to enjoy.
A Garden Where Embroidery Meets Imagination
Across the mall and into Starstreet Precinct, visitors are immersed in a fantastical Chinese landscape of embroidered ornaments, blooming florals, lanterns and gazebos. YLYstudio dedicated over 1,000 hours to handcrafting more than 590 ornaments featuring eight auspicious motifs — feathers, birds, pomegranates, coins, flowers, four-leaf clovers, ladybirds, and clouds — using over 80 types of sequins, threads, and ribbons. These motifs are showcased on the four horses, spreading good fortune while enriching the festive landscape with depth and artistry.
Spring Bloom Gallop Pavilion
Location: Garden Court, Level LG1, Pacific Place
Three embroidered horses stand in quiet splendour — each a symbol of good luck, harmony and prosperity. Rising above them, a five‑metre‑tall gazebo becomes a sanctuary of artistry, where the eight auspicious motifs conceived by YLYstudio are revealed in delicate detail. Each work conveys multicultural blessings, all rendered with exquisite craftsmanship.
Blossoms of Imagination
Location: Level L1 (near lululemon), Pacific Place
Amid peach blossoms, a pastel pavilion shelters two young horses at rest. The scene evokes New Year anticipation, filled with hope and the promise of spring.
‘Splendid Blessings‘ AI Fai Chun Photo Booth
Blending tradition with technology, the ‘Splendid Blessings’ AI Fai Chun Photo Booth invites visitors to create personalised New Year blessings with a contemporary twist.
By registering as an above member and spending HK$300 on the same day via electronic payment, shoppers can select an auspicious message, capture full-body photos, and receive both printed and animated digital versions to take home and share with loved ones.
Date: 5 February – 3 March 2026 Time: 10am – 10pm
Magical Blessings
Location: Level L1 (near Lane Crawford), Pacific Place
Energetic mini horses line both sides of the pathway, accompanied by floral arrangements and whimsical plants that create a festive corridor of movement and charm. An abundance of mini horses extends the blessings along the way, embodying prosperity and joy in every step.
Poised in Bloom
Location: Park Court, Level L1, Pacific Place
At the heart of Park Court, a 3.5‑metre‑tall
giant horse is poised in mid‑gallop — a graceful emblem of blossoming fortune. Flanked by peach blossoms, it moves forward to usher in a more prosperous year ahead.
Lanterns of Serenity
Location: Outside Three Pacific Place on Wing Fung Street and Star Street
Lanterns sway and blossoms bloom in this outdoor extension of the celebration. Set against the urban backdrop of Starstreet Precinct, the installation carries the festive spirit beyond the mall — inviting passersby to pause, smile and soak in the new year fantasy.
Poised in Bloom
‘Blooming Splendour‘ Lai See Packets – Celebrate the Year of the Horse with Flourishing Flowers
The ‘Blooming Splendour’ Lai See packets are inspired by the elegance of embroidery. They feature delicate floral motifs rendered with painterly precision, blending layers of red, pink, and orange threads to create a sense of graceful movement. At the heart of the design, a sculpted floral emblem evokes abundance, beauty, and new beginnings, enriched with pearl-like accents recalling couture embroidery techniques, where beads, sequins and threads are meticulously layered.
Each set includes 10 Lai See packets in two harmonious colourways, accompanied by a velvet pouch in either soft pink, adorned with a pomegranate charm, or rich green, accented with a lucky four-leaf clover charm. These detachable embroidered charms are thoughtfully designed to be worn or styled long after the festive season, carrying the spirit of prosperity and good fortune throughout the year.
‘Galloping Joy‘ – Elevate Your Experience with Exclusive Shopping Rewards
From 5 to 16 February 2026, shoppers can enjoy festive privileges designed to usher in a prosperous year, including exclusive ‘Blooming Splendour’ Lai See packets, movie ticket exchange coupons, Pacific Place shopping e-vouchers and gourmet treats.
Accumulated Same-day Electronic Spending
Shopping Rewards*
HK$3,800 – HK$8,799
One Set of ‘Blooming Splendour’ Lai See Packets + Two MOViE MOViE Pacific Place Ticket Exchange Coupons (valued at HK$260)
—
HK$8,800 – HK$17,999
HK$300 Pacific Place Shopping e-Voucher
HK$18,000 – HK$37,999
HK$600 Pacific Place Shopping e-Voucher + The Grand Sicilian Pistachio Puff (valued at HK$128)
HK$38,000 – HK$87,999
HK$1,400 Pacific Place Shopping e-Voucher + The Grand Sicilian Pistachio Puff (valued at HK$128)
HK$88,000
or above
HK$2,400 Pacific Place Shopping e-Voucher + COVA Nutty Duo Cookie Gift Box (valued at HK$198)
*Shoppers are required to join the Pacific Place Loyalty Programme – above and meet the accumulated same-day spending requirement by electronic payment during the Promotion Period in order to be entitled to redeem Shopping Rewards. The Rewards are limited in quantity and are available on a first-come, first-served basis while stocks last. Other Terms and Conditions apply.
The Year of the Horse arrives in a dance of joy. Step Out Studio and fellow tap dancers will be tapping out the heartbeat of the season, their rhythms galloping alongside the soaring notes of Jazz Band led by Nate Wong. Together, they will conjure a celebration where artistry and vitality run free. After the lions are awakened in an eye‑dotting ritual, our lion dance parade will unfurl like a living tapestry of tradition — spreading fortune, unity and exuberance throughout the mall, and inviting everyone to stride boldly into the year ahead.
Tap and Jazz into the New Season
Let your feet and heart gallop with joy as Step Out Studio and fellow tap dancers bring tap to life, echoing the energy of racing hooves. Accompanied by keyboard, bass, and saxophone from Nate Wong’s Jazz Band, the performance blends percussive footwork with swinging jazz, creating a lively celebration of the Year of the Horse.
Dates:
14 February 2026 – Performers: Cal (Step Out Studio), Zoe Chan, Jazz Band led by Nate Wong
21 February 2026 – Performers: Cal (Step Out Studio), Natalie Hung, Jazz Band led by Nate Wong
Time: 3:30pm
Location: Level L1 (near Shiro), Pacific Place
Roaring into Prosperity: Eye-dotting Ceremony & Lion Dance Parade
Stride into the excitement of the Chinese New Year at Pacific Place! After bringing the lions to life in a traditional eye-dotting ceremony, the lion dance parade will wind its way through the mall, spreading energy, luck, and prosperity for the year ahead.
Date: 23 February 2026 (Monday, 7th day of Chinese New Year)
Time: 1pm
Location: Park Court, Level L1, Pacific Place
Join the ‘Whimsical Gallop’at Pacific Place and Starstreet Precinct this Chinese New Year — where embroidered artistry, festive celebrations, and joyful rewards come together to welcome a year filled with good fortune and blooming possibilities.
The issuer is solely responsible for the content of this announcement.
About YLYstudio
YLYstudio is a Hong Kong-based embroidery atelier celebrated for blending traditional craftsmanship with contemporary design. Founded by Lilian Tsang Lai Yu and Matt Hui Yip Long, the studio brings decades of global fashion experience and artistry to every creation.
Lilian Tsang previously served as chief designer for a Hong Kong fashion label and honed her craft at LECOLE LESAGE, the prestigious haute couture embroidery school owned by the Chanel Group in Paris. She also interned at Elisabeth Gasbarre Rousseau Haute Couture Studio in Lyon, France. With a deep passion for teaching, Lilian now shares her embroidery expertise in Hong Kong, inspiring a new generation of artisans.
Matt Hui is a Hong Kong-based fashion designer graduated from the Royal College of Art in 2013. Passionate about the creative process and fine workmanship, he has collaborated on stage costumes for renowned singers including Panther Chan and Bondy Chiu. Since 2024, Matt has also ventured into the film industry as a custom tailor, contributing to international productions such as Ballad of a Small Player and Emmanuelle.
About Pacific Place
Located in the heart of Admiralty, Pacific Place is the destination for exceptional service and unique experiences. As a pioneer of innovative retail concepts in Hong Kong, Pacific Place continues to transform the retail scene by delighting visitors with an array of curated experiences through diversified offerings. Since its inception in 1988, Pacific Place has established itself as Hong Kong’s premier lifestyle hub, a mixed-use development that continues to evolve and grow as the ultimate destination to shop, dine, work, stay, relax and play. It houses one of Hong Kong’s largest collections of luxury brands and diverse dining offerings, making every visit a memorable one. In addition to being a prime transportation hub, Pacific Place is home to five Grade-A office towers, 268 serviced apartments, and four five-star hotels: The Conrad, Island Shangri-La, JW Marriott and Upper House Hong Kong.
Customer enquiry hotline: (852) 2844 8988
Website: www.pacificplace.com.hk
Facebook: @Pacific Place Hong Kong
Instagram: @pacificplacehk
WeChat: @PacificPlaceHK
XiaoHongShu: @Pacific Place HK
About Starstreet Precinct
Starstreet Precinct is a vibrant destination in Wan Chai, comprised mainly of Wing Fung Street, Star Street, Moon Street, Sun Street, and St. Francis Yard. Over the years, the neighbourhood has evolved from a quaint, historic landmark, into an eclectic hangout hotspot for those with a unique sense of style and character. Filled with cosy cafés, restaurants, bars, boutique shops with the most coveted fashion selections, galleries and interior design stores, the precinct offers an array of day-to-night experiences. With a focus on community and a passion to foster a sustainable lifestyle for all, Starstreet Precinct and its tenants are collectively working to build a better future together. Connected to Pacific Place and Admiralty station through the Three Pacific Place underground link, the neighbourhood is a hidden gem in the heart of Hong Kong.
